🇺🇸 FDA
Patent

US 9840493

Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use

granted A61KA61K47/60A61K47/64

Quick answer

US patent 9840493 (Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use) held by Sutro Biopharma, Inc. expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sutro Biopharma, Inc.
Grant date
Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K47/60, A61K47/64, A61K47/6803, A61K47/68031